We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » GSK Signs on Astex in Partnership for About $33 Million
GSK Signs on Astex in Partnership for About $33 Million
November 13, 2009
GlaxoSmithKline (GSK) has inked a deal with Astex Therapeutics to discover, develop,
and commercialize compounds directed against multiple targets for £20
million (about $33 million) up front. Genetic Engineering & Biotechnology News
